“Efficacy and Safety of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s76. Accessed May 17, 2025. https://skin.dermsquared.com/skin/article/view/1834.